{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:08:20Z","timestamp":1789697300706,"version":"4.0.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2411800"],"award-info":[{"award-number":["2023YFC2411800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024YFHZ0329"],"award-info":[{"award-number":["2024YFHZ0329"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Sichuan Provincial Health Commission","doi-asserted-by":"publisher","award":["2025-106"],"award-info":[{"award-number":["2025-106"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Research Project of Sichuan University","award":["2023SCUH0065"],"award-info":[{"award-number":["2023SCUH0065"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Anticoagulation-free continuous renal replacement therapy (CRRT) is an essential modality for managing patients with a high bleeding risk; however, it confronts significant challenges stemming from a shortened circuit lifespan. Blood flow rate (BFR) has been recognized as a pivotal non-pharmacological determinant influencing circuit longevity. This retrospective cohort study aimed to systematically evaluate whether elevating BFR to 250\u00a0ml\/min could enhance CRRT circuit survival compared with the conventional 200\u00a0ml\/min in anticoagulation-free settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of patients receiving anticoagulation-free CRRT from seven intensive care units at West China Hospital of Sichuan University between September 2023 and June 2024. The primary outcome was circuit lifespan, defined as the duration from CRRT initiation to termination due to clotting or other causes. Protective and risk factors were assessed using univariate and multivariate Cox proportional hazards regression. Secondary outcomes included the proportion of circuits achieving predefined lifespans and patient clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 128 patients using 241 CRRT circuits (median age: 57 years; 74.27% male), circuits were stratified by BFR: 200\u00a0ml\/min (n\u00a0=\u00a0132) and 250\u00a0ml\/min (n\u00a0=\u00a0109). Survival analysis demonstrated significantly improved 72-hour circuit survival in the 250\u00a0ml\/min group for both overall circuits (HR: 0.475, 95% CI: 0.329\u20130.685, P\u00a0&amp;lt;\u00a0.001), clotted circuits (HR: 0.469, 95% CI: 0.321\u20130.685, P\u00a0&amp;lt;\u00a0.001), and each patient\u2019s first circuit (HR: 0.610, 95% CI: 0.373\u20130.998, P\u00a0=\u00a0.046), with results remaining statistically significant after confounder adjustment. The 250\u00a0ml\/min group exhibited longer median circuit lifespans (overall: 33.5\u00a0vs. 13 hours; clotted: 31\u00a0vs. 15.5 hours; first circuit: 37\u00a0vs. 18 hours; all P\u00a0&amp;lt;\u00a0.05) and higher proportions of circuits achieving predefined lifespans (12 h: 85.32%\u00a0vs. 65.91%; 24 h: 64.22%\u00a0vs. 30.30%; 48 h: 33.94%\u00a0vs. 9.09%; 72 h: 13.76%\u00a0vs. 3.79%; all P\u00a0&amp;lt;\u00a0.05). Multivariate analysis identified use of ST150 filter, exposure to non-CRRT anticoagulation agents, and higher activated partial thromboplastin time as protective factors, whereas higher substitute fluid rate, hyperlipidemia, and hematocrit \u22650.30 were associated with reduced circuit survival. Clinically, the 250\u00a0ml\/min group had lower in-hospital mortality (65.14%\u00a0vs. 81.06%, P\u00a0=\u00a0.005). Mediation analysis revealed that higher BFR might prolong circuit lifespan by reducing transmembrane pressure (TMP) increase, which accounted for up to 60.32% of the protective effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A BFR of 250\u00a0ml\/min significantly improved circuit survival in anticoagulation-free CRRT compared to 200\u00a0ml\/min, likely mediated by TMP reduction. Moreover, patients receiving 250\u00a0ml\/min BFR exhibited lower in-hospital mortality. Our results support adopting a higher BFR to optimize CRRT efficacy in anticoagulation-free settings. Larger-scale prospective trials are needed to validate the findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf360","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:36:55Z","timestamp":1763645815000},"source":"Crossref","is-referenced-by-count":4,"title":["Higher blood flow rates in anticoagulation-free CRRT improve circuit survival and clinical outcome"],"prefix":"10.1093","volume":"19","author":[{"given":"Caihong","family":"Liu","sequence":"first","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Fan","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University\/West China School of Nursing, Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyao","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University\/West China School of Nursing, Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiu","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Chen","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University\/West China School of Nursing, Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongxing","family":"Bu","sequence":"additional","affiliation":[{"name":"Heping Hospital of Changzhi Medical College Department of Nephrology, , Changzhi ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University\/West China School of Nursing, Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tang","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University\/West China School of Nursing, Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fu","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7660-452X","authenticated-orcid":false,"given":"Yuliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Kidney Diseases, West China Hospital of Sichuan University Department of Nephrology, , Chengdu ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2026010204362771900_bib1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/BF02425162","article-title":"Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation","volume":"21","author":"Webb","year":"1995","journal-title":"Intensive Care Med"},{"key":"2026010204362771900_bib2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/cc5937","article-title":"Clinical review: patency of the circuit in continuous renal replacement therapy","volume":"11","author":"Joannidis","year":"2007","journal-title":"Crit Care"},{"key":"2026010204362771900_bib3","first-page":"CD012467","article-title":"Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy","volume":"12","author":"Tsujimoto","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010204362771900_bib4","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","article-title":"Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators","volume":"33","author":"Uchino","year":"2007","journal-title":"Intensive Care Med"},{"key":"2026010204362771900_bib5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/NEJMoa0802639","article-title":"Intensity of renal support in critically ill patients with acute kidney injury","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"2026010204362771900_bib6","doi-asserted-by":"publisher","first-page":"744.e7","DOI":"10.1016\/j.jcrc.2012.08.016","article-title":"Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure","volume":"27","author":"Chua","year":"2012","journal-title":"J Crit Care"},{"key":"2026010204362771900_bib7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/039139881003300302","article-title":"Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill?","volume":"33","author":"Kleger","year":"2010","journal-title":"Int J Artif Organs"},{"key":"2026010204362771900_bib8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000380904","article-title":"Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous hemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities","volume":"39","author":"Schilder","year":"2015","journal-title":"Blood Purif"},{"key":"2026010204362771900_bib9","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/cc11403","article-title":"Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution","volume":"16","author":"Morabito","year":"2012","journal-title":"Crit Care"},{"key":"2026010204362771900_bib10","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s001340000691","article-title":"Continuous veno-venous hemofiltration without anticoagulation in high-risk patients","volume":"26","author":"Tan","year":"2000","journal-title":"Intensive Care Med"},{"key":"2026010204362771900_bib11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1036-7314(06)80026-3","article-title":"Maintaining the CRRT circuit: non-anticoagulant alternatives","volume":"19","author":"Davies","year":"2006","journal-title":"Aust Crit Care"},{"key":"2026010204362771900_bib12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/PCC.0b013e318297626e","article-title":"Improving delivery of continuous renal replacement therapy: impact of a simulation-based educational intervention","volume":"14","author":"Mottes","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"2026010204362771900_bib13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1441-2772(23)01477-1","article-title":"Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables","volume":"16","author":"Dunn","year":"2014","journal-title":"Crit Care Resuscit"},{"key":"2026010204362771900_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000102081","article-title":"Factors affecting circuit patency and filter \u201clife\u201d","volume":"156","author":"Baldwin","year":"2007","journal-title":"Contrib Nephrol"},{"key":"2026010204362771900_bib15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13054-023-04519-1","article-title":"Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou","year":"2023","journal-title":"Crit Care"},{"key":"2026010204362771900_bib16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12882-017-0445-5","article-title":"Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis","volume":"18","author":"Brain","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026010204362771900_bib17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1186\/s12912-025-03762-x","article-title":"Saline flushing to prevent circuit clotting during CRRT without anticoagulant: a randomized controlled study","volume":"24","author":"Wang","year":"2025","journal-title":"BMC Nurs"},{"key":"2026010204362771900_bib18","first-page":"55","article-title":"Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial","volume":"53","author":"Ramesh Prasad","year":"2000","journal-title":"Clin Nephrol"},{"key":"2026010204362771900_bib19","doi-asserted-by":"publisher","first-page":"e1018","DOI":"10.1097\/CCM.0000000000002568","article-title":"Faster Blood flow rate does not improve circuit life in continuous renal replacement therapy: a randomized controlled trial","volume":"45","author":"Fealy","year":"2017","journal-title":"Crit Care Med"},{"key":"2026010204362771900_bib20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1159\/000519409","article-title":"Development and external validation of a model for predicting sufficient filter lifespan in anticoagulation-free continuous renal replacement therapy patients","volume":"51","author":"Zhang","year":"2022","journal-title":"Blood Purif"},{"key":"2026010204362771900_bib21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/039139880102400601","article-title":"Renal replacement therapy: physical properties of hollow fibers influence efficiency","volume":"24","author":"D\u00fcngen","year":"2001","journal-title":"Int J Artif Organs"},{"key":"2026010204362771900_bib22","doi-asserted-by":"publisher","first-page":"e13179","DOI":"10.1111\/nicc.13179","article-title":"What influences interruption of continuous renal replacement therapy in intensive care unit patients: a review with meta-analysis on outcome variables","volume":"30","author":"Xiaomei","year":"2025","journal-title":"Nurs Crit Care"},{"key":"2026010204362771900_bib23","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00467-017-3601-z","article-title":"Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits","volume":"32","author":"Kakajiwala","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2026010204362771900_bib24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.aucc.2023.11.005","article-title":"Haematocrit monitoring and blood volume estimation during continuous renal replacement therapy","volume":"37","author":"Baldwin","year":"2024","journal-title":"Aust Crit Care"},{"key":"2026010204362771900_bib25","first-page":"CD013330","article-title":"Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy","author":"Miki","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010204362771900_bib26","doi-asserted-by":"publisher","first-page":"c94","DOI":"10.1159\/000072492","article-title":"Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control","volume":"94","author":"Uchino","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"2026010204362771900_bib27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/sdi.13147","article-title":"An evaluation of different dilution modes on circuit lifespan during continuous veno-venous hemodiafiltration without anticoagulation","volume":"37","author":"Wang","year":"2024","journal-title":"Semin Dial"},{"key":"2026010204362771900_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40635-023-00581-9","article-title":"Metabolic disturbances potentially attributable to clogging during continuous renal replacement therapy","volume":"11","author":"M\u00fcller","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"2026010204362771900_bib29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41100-023-00496-x","article-title":"Propofol infusion syndrome as a cause for CRRT circuit malfunction: a case report with literature review","volume":"9","author":"Zambon","year":"2023","journal-title":"Ren Replace Ther"},{"key":"2026010204362771900_bib30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00134-019-05592-3","article-title":"Green plasma and a blocked CRRT circuit due to drug-induced hyperlipidemia","volume":"45","author":"Cardinale","year":"2019","journal-title":"Intensive Care Med"},{"key":"2026010204362771900_bib31","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.2215\/CJN.02410220","article-title":"Revisiting filtration fraction as an index of the risk of hemofilter clotting in continuous venovenous hemofiltration","volume":"15","author":"Hatamizadeh","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026010204362771900_bib32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MAT.0b013e31815d6898","article-title":"Platelet activation due to hemodynamic shear stresses: damage accumulation model and comparison to in vitro measurements","volume":"54","author":"Nobili","year":"2008","journal-title":"ASAIO J"},{"key":"2026010204362771900_bib33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000441968","article-title":"Patterns and mechanisms of artificial kidney failure during continuous renal replacement therapy","volume":"41","author":"Zhang","year":"2016","journal-title":"Blood Purif"},{"key":"2026010204362771900_bib34","first-page":"1","article-title":"Impact of No Anticoagulation, citrate anticoagulation, and heparin anticoagulation on crrt outcomes in patients with hyperlactatemia: a retrospective cohort study","author":"Xiong","year":"2025","journal-title":"Blood Purif"},{"key":"2026010204362771900_bib35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3904\/kjim.2015.111","article-title":"The impact of blood flow rate during hemodialysis on all-cause mortality","volume":"31","author":"Chang","year":"2016","journal-title":"Korean J Intern Med"},{"key":"2026010204362771900_bib36","doi-asserted-by":"publisher","first-page":"e0330845","DOI":"10.1371\/journal.pone.0330845","article-title":"Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study)","volume":"20","author":"Liu","year":"2025","journal-title":"PLoS ONE"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf360\/65450010\/sfaf360.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/1\/sfaf360\/65450010\/sfaf360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/1\/sfaf360\/65450010\/sfaf360.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:36:36Z","timestamp":1767346596000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf360\/8339706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf360","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,21]]},"article-number":"sfaf360"}}